Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liang-Chi Chen

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Anticancer Research|February 2, 2024
Prognostic Value of Immune Cells Subsets Within the Tumor Microenvironment in Patients With Rectal AdenocarcinomaTao-Wei Ke, Senamile Temhlanga Zwane, Shu-Fen Chiang, et al.
Journal of Cancer|February 19, 2024
Dual Inhibition of B7-H3 and EGFR Overcomes Acquired Chemoresistance in Colon AdenocarcinomaLiang-Chi Chen, Pei-Chen Yang, Chia-Yi Chen, et al.
Scientific Reports|November 9, 2023
Dysfunctional TLR1 reduces the therapeutic efficacy of chemotherapy by attenuating HMGB1-mediated antitumor immunity in locally advanced colorectal cancerKevin Chih-Yang Huang, Tao-Wei Ke, Jia-Yi Chen, et al.
Anticancer Research|March 28, 2023
Pelvic Neoadjuvant Radiotherapy for Stage M1a Rectal Adenocarcinoma Patients Treated With Systemic Therapy Followed by Proctectomy and Metastasectomy: A Nationwide Retrospective Cohort StudyTao-Wei Ke, Sheng-Chi Chang, Hung-Chang Chen, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Anticancer Research|February 2, 2024
Prognostic Value of Immune Cells Subsets Within the Tumor Microenvironment in Patients With Rectal AdenocarcinomaTao-Wei Ke, Senamile Temhlanga Zwane, Shu-Fen Chiang, et al.
Journal of Cancer|February 19, 2024
Dual Inhibition of B7-H3 and EGFR Overcomes Acquired Chemoresistance in Colon AdenocarcinomaLiang-Chi Chen, Pei-Chen Yang, Chia-Yi Chen, et al.
Scientific Reports|November 9, 2023
Dysfunctional TLR1 reduces the therapeutic efficacy of chemotherapy by attenuating HMGB1-mediated antitumor immunity in locally advanced colorectal cancerKevin Chih-Yang Huang, Tao-Wei Ke, Jia-Yi Chen, et al.
Anticancer Research|March 28, 2023
Pelvic Neoadjuvant Radiotherapy for Stage M1a Rectal Adenocarcinoma Patients Treated With Systemic Therapy Followed by Proctectomy and Metastasectomy: A Nationwide Retrospective Cohort StudyTao-Wei Ke, Sheng-Chi Chang, Hung-Chang Chen, et al.
Pageof 2